ArticleLiver international : official journal of the International Association for the Study of the Liver2026

Stratifying Cardiovascular Risk in Patients With HCC Receiving Atezolizumab/Bevacizumab: A Comparison of ESC and CARDIOSOR Scores.

Bernardo Stefanini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.